Webinar:

EU Market Access, Pricing and Reimbursement. Current and Future Trends in Oncology

Sponsored by: GlobalData

Focused on:

  • Oncology
  • Eu Market Access

Date: 25 September

Days to go: 4

Time: 3PM London/10AM New York

Market access of oncology medicines is increasingly challenging due to the economic pressures on national budgets and health systems, the rising cost of new and innovative medicines and the more rigorous scientific and value assessments of medicines. Although 5EU markets have implemented access schemes to ensure early access to innovative oncology medicines with high unmet need, the increasing requirements for improved clinical benefits and better cost-effectiveness of medicines has resulted in more stringent pricing and reimbursement measures for medicines, leading to various access issues. Benefiting from GlobalData’s unique core of expertise, a new report has been published by the company identifying the current and future outlook of the market access landscape in the 5EU.

In this webinar, GlobalData’s Oncology and Hematology Analyst, Tajekesa Chapman, will provide a brief overview of market access, pricing and reimbursement in the 5EU (France, Germany, Italy, Spain and UK) integrated with insights from pharmaceutical and healthcare key opinion leaders and payers. The webinar will also discuss the unmet needs, challenges and opportunities in oncology and introduce the market access trends, drivers and barriers identified through exclusive expert interviews and primary research.

Dr. Heather Leach, GlobalData’s Oncology and Hematology Associate Director, will moderate a Q&A session following the presentation. Join this webinar to increase your knowledge of the current and future outlook of market access in oncology in the 5EU and how GlobalData can help you understand the impact on your business.

Presented by

Tajekesa Chapman,

Analyst, Oncology and Hematology

Tajekesa Chapman, PhD, is an Oncology and Hematology Analyst at GlobalData in London. Prior to joining GlobalData Healthcare, she completed her PhD in Biochemistry and Molecular Biology from the University of Edinburgh where she investigated the importance of regulated post-translational gene expression in normal development. Following this, she was responsible for the provision of pharmaceutical medical information and pharmacovigilance, on behalf of pharmaceutical companies and in various therapy and disease areas such as oncology, immunology, hematology, cardiology and respiratory. Most recently, Tajekesa has worked for the British Standards Institution, where she facilitated the development of scientific and engineering industry standards, particularly in biomedical, oil & gas industries and emerging areas such as synthetic biology, FinTech, advanced materials (graphene). Tajekesa also holds a BSc in Biochemistry and Genetics from the University of Nottingham where she undertook research projects relating to antibiotic resistance and cancer cell biology.

Heather Leach,

Associate Director, Oncology and Hematology

Heather Leach, PhD, is the Associate Director (AD) of Oncology and Hematology at GlobalData in New York City. Heather has 10 years of basic research experience in molecular biology and immunology and several years’ experience as an analyst and consultant for the biopharmaceutical industry. Prior to joining GlobalData as an AD, she worked as an analyst in immunology and neurology and as a consultant for a boutique life sciences consulting firm in New York City. She has worked in various academic and pharmaceutical research labs at the University of Connecticut, Boston University School of Medicine, and Pfizer, covering human diseases such as sepsis, systemic sclerosis, and idiopathic pulmonary fibrosis. Heather holds a Bachelor’s degree in Molecular and Cell Biology from the University of Connecticut, and a PhD in Pathology and Cell and Molecular Biology from Boston University School of Medicine.

Key Learning Objectives

  • Understand the key concepts, current and future landscapes for oncology market access in the 5EU
  • Understand the challenges and opportunities for oncology market access in the 5EU
  • Gain insight from key opinion leaders, payers and GlobalData’s specialist oncology analysts.
  • See how GlobalData’s insights can support your organization’s market access capabilities

Audience

  • Managers
  • Senior Managers
  • Associate Directors/Directors of Market Research
  • Business Insights
  • Market Intelligence
  • Strategic Insights
  • Forecasting
  • Pipeline Management
  • Competitive Strategy
  • Customer Insights
  • Heads of Research and Development
  • Heads of Product Planning and Marketing
  • Brand Managers
  • Market Access
  • Health Economics and Outcomes Research
  • Pharmaceutical Pricing
  • Pharmaceutical Licensing
  • Government and Public Affairs
  • Drug Development
  • Regulatory Affairs
  • Medical Affairs
  • Market Access Consultant